GLYONIC aims at continuously improving both upstream and downstream processes and maximizing product yield. State of the art parallel bioreactors allow for characterization of engineered production strains and quick adjustment of process parameters. The products from our proprietary bioconversion technology are purely isolated from the fermentation via modern adsorptive separation techniques. Constantly pushing our limits, we are focusing on increasing the efficiency of our bioprocess.